Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1)
- PMID: 21896490
- PMCID: PMC3199464
- DOI: 10.1074/jbc.M110.204040
Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1)
Abstract
The activation of naïve T cells requires antigen presentation by dendritic cells (DCs), and the process of antigen presentation is regulated over the course of DC maturation. One key aspect of this regulation is the cell surface up-regulation upon DC maturation of peptide·MHC-II complexes and the costimulatory molecule CD86. It is now clear that these critical induction events involve changes in ubiquitin-dependent trafficking of MHC-II and CD86 by the E3 ligase membrane-associated RING-CH-1 (MARCH1). Although ubiquitin-dependent trafficking of MHC-II has been well characterized, much less is known regarding the post-transcriptional regulation of CD86 expression. Here, we examined the physical and functional interaction between CD86 and MARCH1. We observed that CD86 is rapidly endocytosed in the presence of MARCH1 followed by lysosome-dependent degradation. Furthermore, we found that the association between CD86 and MARCH1 was conferred primarily by the transmembrane domains of the respective proteins. In contrast to MHC-II, which has a single, conserved ubiquitin acceptor site in the cytosolic domain, we found that multiple lysine residues in the cytosolic tail of CD86 could support ubiquitination consistent with the relative lack of sequence conservation across species within the CD86 cytosolic domain. These findings suggest that MARCH1 recruits multiple substrates via transmembrane domain-mediated interactions to permit substrate ubiquitination in the face of diverse cytosolic domain sequences.
Figures






Similar articles
-
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.J Exp Med. 2011 Jan 17;208(1):149-65. doi: 10.1084/jem.20092203. Epub 2011 Jan 10. J Exp Med. 2011. PMID: 21220452 Free PMC article.
-
Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.J Immunol. 2011 Sep 15;187(6):2966-73. doi: 10.4049/jimmunol.1101643. Epub 2011 Aug 17. J Immunol. 2011. PMID: 21849678 Free PMC article.
-
Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.J Immunol. 2009 Nov 15;183(10):6500-12. doi: 10.4049/jimmunol.0901521. Epub 2009 Oct 30. J Immunol. 2009. PMID: 19880452 Free PMC article.
-
MARCH ligases in immunity.Curr Opin Immunol. 2019 Jun;58:38-43. doi: 10.1016/j.coi.2019.03.001. Epub 2019 May 4. Curr Opin Immunol. 2019. PMID: 31063934 Review.
-
RING domain E3 ubiquitin ligases.Annu Rev Biochem. 2009;78:399-434. doi: 10.1146/annurev.biochem.78.101807.093809. Annu Rev Biochem. 2009. PMID: 19489725 Review.
Cited by
-
The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination.Front Immunol. 2024 Aug 9;15:1423069. doi: 10.3389/fimmu.2024.1423069. eCollection 2024. Front Immunol. 2024. PMID: 39185411 Free PMC article. Review.
-
Isoforms of Human MARCH1 Differ in Ability to Restrict Influenza A Viruses Due to Differences in Their N Terminal Cytoplasmic Domain.Viruses. 2022 Nov 18;14(11):2549. doi: 10.3390/v14112549. Viruses. 2022. PMID: 36423158 Free PMC article.
-
Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.Toxicology. 2013 Aug 9;310:84-91. doi: 10.1016/j.tox.2013.05.009. Epub 2013 May 29. Toxicology. 2013. PMID: 23727458 Free PMC article.
-
The Membrane Associated RING-CH Proteins: A Family of E3 Ligases with Diverse Roles through the Cell.Int Sch Res Notices. 2014 Oct 29;2014:637295. doi: 10.1155/2014/637295. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27419207 Free PMC article. Review.
-
Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability.Front Immunol. 2018 Jun 13;9:1328. doi: 10.3389/fimmu.2018.01328. eCollection 2018. Front Immunol. 2018. PMID: 29951065 Free PMC article.
References
-
- Heath W. R., Carbone F. R. (2009) Nat. Immunol. 10, 1237–1244 - PubMed
-
- Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J. W., Pascual V., Palucka A. K., Banchereau J. (2007) Immunol. Rev. 219, 118–142 - PubMed
-
- Banchereau J., Steinman R. M. (1998) Nature 392, 245–252 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials